x

Century Therapeutics, Inc. (Nasdaq:IPSC)

Health Care/Life Sciences • Biotechnology
CIK 1850119
Company

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Address
3675 Market Street
Philadelphia, Pennsylvania 19104
Employees
163
Stock Info
Close
$4.2500
Day Range
4.0600 - 4.3392
52 Week Range
1.2800 - 5.3399
Average volume
240.94K
Short Interest
1.81M (02/15/24)
% of Float Shorted
7.69%
Market Cap
$245.32M
Revenue
$5.2M
Net Income
-$130.93M
2020 Sales Growth
N/A
Rev. per Employee
$15.26K
P/E Ratio
N/A
EPS
-$2.1888
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
Brent Pfeiffenberger PharmD
Chairman
Joseph Jimenez Jr., MBA
Independent Director
Alessandro Riva MD
Independent Director
Cynthia M Butitta MBA
Independent Director
Kimberly L Blackwell MD
Independent Director
Daphne E Quimi CPA, MBA
Independent Director
Timothy P Walbert
Independent Director
Carlo Rizzuto PhD
SEC filings
DateFormEvent
8 Aug, 2024 10-Q
8 Aug, 2024 8-K
7 Aug, 2024 4
7 Aug, 2024 4
5 Aug, 2024 144
31 Jul, 2024 4
26 Jul, 2024 144
25 Jul, 2024 4
24 Jul, 2024 144
23 Jul, 2024 144
8 Jul, 2024 8-K
26 Jun, 2024 EFFECT
26 Jun, 2024 8-K/A
26 Jun, 2024 424B3
25 Jun, 2024 CORRESP
24 Jun, 2024 8-K
24 Jun, 2024 UPLOAD
24 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 4
20 Jun, 2024 144
18 Jun, 2024 S-3
10 Jun, 2024 4
6 Jun, 2024 4
5 Jun, 2024 144
3 Jun, 2024 8-K
22 May, 2024 424B3
21 May, 2024 EFFECT
21 May, 2024 4
20 May, 2024 144
17 May, 2024 CORRESP
17 May, 2024 UPLOAD
15 May, 2024 S-3
9 May, 2024 10-Q
9 May, 2024 8-K
7 May, 2024 4
7 May, 2024 4
7 May, 2024 4
6 May, 2024 144
3 May, 2024 144
26 Apr, 2024 DEF 14A
26 Apr, 2024 DEFA14A
26 Apr, 2024 ARS
25 Apr, 2024 SC 13G
24 Apr, 2024 4
22 Apr, 2024 144
22 Apr, 2024 SC 13G
18 Apr, 2024 SC 13G
16 Apr, 2024 PRE 14A
11 Apr, 2024 8-K
11 Apr, 2024 8-K
9 Apr, 2024 8-K
8 Apr, 2024 SC 13D/A
20 Mar, 2024 144
18 Mar, 2024 4
18 Mar, 2024 144
15 Mar, 2024 144
14 Mar, 2024 S-8
14 Mar, 2024 10-K
14 Mar, 2024 8-K
11 Mar, 2024 4
11 Mar, 2024 4
11 Mar, 2024 4
11 Mar, 2024 4
8 Mar, 2024 4
7 Mar, 2024 144
7 Mar, 2024 144
6 Mar, 2024 144
6 Mar, 2024 144
4 Mar, 2024 SC 13G
21 Feb, 2024 4
21 Feb, 2024 144/A
16 Feb, 2024 144
9 Feb, 2024 SC 13G/A
8 Feb, 2024 SC 13G/A
7 Feb, 2024 4
7 Feb, 2024 4
6 Feb, 2024 144
6 Feb, 2024 144
5 Feb, 2024 144
5 Feb, 2024 144
11 Dec, 2023 8-K
6 Dec, 2023 8-K
6 Dec, 2023 4
6 Dec, 2023 3
14 Nov, 2023 8-K CEO Change
13 Nov, 2023 SC 13G/A
9 Nov, 2023 8-K
9 Nov, 2023 10-Q
3 Nov, 2023 4
3 Nov, 2023 4
3 Oct, 2023 8-K
9 Aug, 2023 10-Q
9 Aug, 2023 8-K
29 Jun, 2023 4
29 Jun, 2023 8-K
29 Jun, 2023 4
29 Jun, 2023 4
29 Jun, 2023 4
29 Jun, 2023 4
29 Jun, 2023 4
29 Jun, 2023 4
17 May, 2023 4
17 May, 2023 4
11 May, 2023 10-Q
11 May, 2023 8-K
5 May, 2023 8-K/A
5 May, 2023 8-K
28 Apr, 2023 DEF 14A
28 Apr, 2023 ARS
28 Apr, 2023 DEFA14A
17 Apr, 2023 8-K CEO Change
14 Apr, 2023 4
14 Apr, 2023 3
13 Apr, 2023 4
5 Apr, 2023 4
23 Mar, 2023 4
23 Mar, 2023 144
22 Mar, 2023 144
21 Mar, 2023 144
20 Mar, 2023 8-K
17 Mar, 2023 S-8
16 Mar, 2023 10-K
16 Mar, 2023 8-K
13 Mar, 2023 8-K
9 Feb, 2023 SC 13G/A
9 Feb, 2023 SC 13G/A
6 Feb, 2023 4
6 Feb, 2023 4
6 Feb, 2023 4
6 Feb, 2023 4
6 Feb, 2023 4
6 Feb, 2023 4
9 Jan, 2023 8-K
30 Nov, 2022 8-K
10 Nov, 2022 8-K
10 Nov, 2022 8-K
10 Nov, 2022 10-Q
11 Oct, 2022 SC 13D/A
3 Oct, 2022 3
3 Oct, 2022 8-K
3 Oct, 2022 4
3 Oct, 2022 4
3 Oct, 2022 3
8 Sep, 2022 8-K
25 Aug, 2022 8-K
11 Aug, 2022 10-Q
11 Aug, 2022 8-K
11 Aug, 2022 4
13 Jul, 2022 EFFECT
11 Jul, 2022 CORRESP
8 Jul, 2022 UPLOAD
1 Jul, 2022 8-K
1 Jul, 2022 S-3
13 Jun, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
16 May, 2022 10-Q
16 May, 2022 8-K
10 May, 2022 8-K
21 Apr, 2022 DEF 14A
21 Apr, 2022 DEFA14A
13 Apr, 2022 8-K
17 Mar, 2022 10-K
17 Mar, 2022 S-8
17 Mar, 2022 8-K
11 Feb, 2022 SC 13G
11 Feb, 2022 SC 13G
11 Feb, 2022 SC 13G
9 Feb, 2022 SC 13G/A
2 Feb, 2022 4
27 Jan, 2022 4
27 Jan, 2022 4
27 Jan, 2022 4
27 Jan, 2022 4
27 Jan, 2022 4
27 Jan, 2022 4
27 Jan, 2022 4
13 Jan, 2022 8-K
11 Jan, 2022 8-K
10 Jan, 2022 8-K
28 Dec, 2021 4
16 Dec, 2021 8-K
18 Nov, 2021 8-K
10 Nov, 2021 8-K
10 Nov, 2021 10-Q
13 Oct, 2021 8-K
12 Aug, 2021 8-K
12 Aug, 2021 10-Q
10 Aug, 2021 SC 13G
29 Jul, 2021 SC 13D
2 Jul, 2021 S-8
25 Jun, 2021 8-K
23 Jun, 2021 4
23 Jun, 2021 4
23 Jun, 2021 4
22 Jun, 2021 4
21 Jun, 2021 4
21 Jun, 2021 4
21 Jun, 2021 4
21 Jun, 2021 4
21 Jun, 2021 4
21 Jun, 2021 4
21 Jun, 2021 424B4 IPO completed
17 Jun, 2021 3
17 Jun, 2021 SEC STAFF
17 Jun, 2021 EFFECT
17 Jun, 2021 CERT
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
17 Jun, 2021 3
16 Jun, 2021 CERT
16 Jun, 2021 CERT
15 Jun, 2021 S-1/A
15 Jun, 2021 CORRESP
15 Jun, 2021 CORRESP
14 Jun, 2021 8-A12B
14 Jun, 2021 S-1/A
10 Jun, 2021 CORRESP
7 Jun, 2021 SEC STAFF
28 May, 2021 S-1
28 May, 2021 CORRESP
21 May, 2021 UPLOAD
18 May, 2021 SEC STAFF
5 May, 2021 DRSLTR
5 May, 2021 DRS/A
23 Apr, 2021 UPLOAD
26 Mar, 2021 DRS
15 Mar, 2021 D
Last update:2024-03-06 13:28:41.897344
Century Therapeutics, Inc. by TradingView

Sign Up to Subscribe